Status:
COMPLETED
Application of Mindfulness Meditation Based on Brain Computer Interface in Radiofrequency Ablation
Lead Sponsor:
The First Affiliated Hospital with Nanjing Medical University
Conditions:
Atrial Fibrillation
Radiofrequency Ablation
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
In recent years, radiofrequency ablation has gradually become a first-line treatment for patients with atrial fibrillation. Radiofrequency ablation is an invasive procedure that lasts several hours, p...
Detailed Description
1. Research Background Atrial fibrillation is one of the most common arrhythmias in the world. According to 2020 ESC atrial fibrillation management guidelines, the global prevalence of atrial fibr...
Eligibility Criteria
Inclusion
- Clinical diagnosis of Atrial Fibrillation
- Age ≥ 18 years
- First radiofrequency ablation treatment
- Informed consent, voluntary participation
Exclusion
- With serious organic diseases such as malignant tumors
- With a history of mental illness or cognitive dysfunction, unable to correctly understand the questionnaire and intervention content
- Patients who are forced to or voluntarily withdraw due to changes in their condition
Key Trial Info
Start Date :
April 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 3 2023
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05306015
Start Date
April 1 2022
End Date
May 3 2023
Last Update
February 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, China, 210000